300957.SHE Yunnan Botanee Bio-Technology Group Co Ltd
- Market cap
- CNY 12.3B
- P/E
- 22.5x
- P/B
- 2.03x
- ROE
- 6.8%
- Dividend yield
- 2.16%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300957.SHE undervalued?
Graham number300957.SHE trades 42.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Yunnan Botanee Bio-Technology Group Co Ltd fundamental analysis
No fundamental analysis for Yunnan Botanee Bio-Technology Group Co Ltd yet.
Yunnan Botanee Bio-Technology Group Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. It operates through Skin Care Products, Medical Instruments, and Makeup segments. The company offers face creams, toners, masks, serums, and lotions; and makeup products, including primers, powders, BB creams, and makeup removers. It is also involved in the research, development, production, and sale…
Full company profileYunnan Botanee Bio-Technology Group Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Yunnan Botanee Bio-Technology Group Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 798M | 1.24B | 1.94B | 2.64B | 4.02B | 5.01B | 5.73B | 5.74B | 5.36B | 4.85B |
| Gross Profit | 644M | 1.00B | 1.55B | 2.00B | 3.05B | 3.75B | 4.27B | 4.17B | 3.99B | 3.62B |
| Operating Income | 186M | 313M | 502M | 650M | 1.02B | 1.21B | 878M | 625M | 574M | 404M |
| EBITDA | 186M | 306M | 488M | 660M | 968M | 1.11B | 954M | 516M | 849M | 495M |
| Net Income | 154M | 261M | 412M | 544M | 863M | 1.05B | 757M | 503M | 506M | 413M |
| EPS | 0.43 | 0.72 | 0.97 | 1.28 | 2.04 | 2.48 | 1.79 | 1.20 | 1.19 | 0.98 |
| Balance Sheet | ||||||||||
| Total Assets | 502M | 764M | 1.08B | 1.68B | 5.81B | 6.72B | 7.51B | 8.30B | 8.34B | 7.97B |
| Total Liabilities | 239M | 313M | 323M | 482M | 1.03B | 1.12B | 1.49B | 2.12B | 2.04B | 1.84B |
| Shareholders' Equity | 255M | 445M | 756M | 1.20B | 4.76B | 5.55B | 5.86B | 6.05B | 6.16B | 6.05B |
| Cash & Short-term Investments | 263M | 251M | 527M | 752M | 2.82B | 3.95B | 3.33B | 4.24B | 2.46B | 1.61B |
| Total Debt | - | - | 15.0M | 53.2M | 76.3M | 50.9M | 172M | 754M | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 202M | 102M | 515M | 431M | 1.15B | 769M | 610M | 695M | 977M | - |
| Capital Expenditure | 13.6M | 31.6M | 61.0M | 89.5M | 271M | 353M | 274M | 378M | 483M | 67.0M |
| Free Cash Flow | 189M | 70.6M | 454M | 342M | 882M | 416M | 336M | 316M | 494M | 355M |
| Ratios | ||||||||||
| ROE | 60.3% | 58.5% | 54.5% | 45.3% | 18.1% | 18.9% | 12.9% | 8.3% | 8.2% | 6.8% |
| ROA | 30.6% | 34.1% | 38.0% | 32.3% | 14.8% | 15.6% | 10.1% | 6.1% | 6.1% | 5.2% |
| Net Profit Margin | 19.3% | 21.0% | 21.2% | 20.6% | 21.5% | 21.0% | 13.2% | 8.8% | 9.4% | 8.5% |
| Debt to Equity | - | - | 0.02x | 0.04x | 0.02x | 0.01x | 0.03x | 0.12x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Yunnan Botanee Bio-Technology Group Co Ltd dividends
- Dividend yield
- 2.16%
- Forward dividend
- 0.80 CNY
- Payout ratio
- 52.5%
- Ex-dividend date
- Sep 22, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 266M | 0.63 | 52.5% |
| 2024 | CNY 263M | 0.63 | 52.2% |
| 2023 | CNY 339M | 0.80 | 44.8% |
| 2022 | CNY 55.5M | 0.13 | 5.3% |
| 2021 | CNY 191M | 0.45 | 22.1% |
| 2020 | CNY 101M | 0.24 | 18.5% |
| 2019 | CNY 191M | 0.45 | 46.3% |
| 2018 | 37.4M | 0.10 | 14.3% |
| 2017 | 1.38M | 0.00 | 0.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Yunnan Botanee Bio-Technology Group Co Ltd
- Insiders 49.76%
- Institutions 12.00%
- Public & others 38.24%
- Shares outstanding 424M
- Free float 203M
Yunnan Botanee Bio-Technology Group Co Ltd company profile
- Company name
- Yunnan Botanee Bio-Technology Group Co Ltd
- Ticker
- 300957.SHE
- ISIN
- CNE100004G74
- Exchange
- Shenzhen Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 3,574
- Fiscal year end
- December
- Address
- No. 53, Keyi Road, Kunming, China, 650106
- Phone
- 86 871 6801 2999
- Website
- botanee.com.cn
About Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. It operates through Skin Care Products, Medical Instruments, and Makeup segments. The company offers face creams, toners, masks, serums, and lotions; and makeup products, including primers, powders, BB creams, and makeup removers. It is also involved in the research, development, production, and sale of skincare related medical devices and electronic beauty instruments comprising hyaluronic acid repair bio membranes and hyaluronic acid repair dressings used for the protection and care of skin barrier damage after minimally invasive surgery; provision of provision of supply chain management, warehouse services, capital market, and consulting services. In addition, the company offers home-use electronic radiofrequency beauty devices. Further, it offers Qiumei App, an AI system for common skin problems; and medical cosmetic centers that provide vocational training, organization operation, member management, activity planning, and advertising support under the Vvym brand name. The company sells its products under Winona, Winona Baby, AOXMED, Beforteen, Za, and PURE&MILD brand names through offline and online channels, such as e-commerce platforms, retail, large key account (KA) clients, OTC chain clients, commercial companies, and regional distributors. Yunnan Botanee Bio-Technology Group Co.LTD was incorporated in 2010 and is headquartered in Kunming, China.
Yunnan Botanee Bio-Technology Group Co Ltd management
9- Mr. Zhenyu GuoGM & Non-Independent Chairman of the Board · born 1963
- Mr. Long WangDeputy GM, CFO & Secretary of Board · born 1982
- Mr. Shaoyang GaoSenior VP & Director · born 1976
- Mr. Xiao MaSenior Vice President & Non-Independent Director · born 1982
- Ms. Mei ZhangDeputy GM & Employee Representative Director · born 1979
- Mr. Feifei WangDeputy General Manager · born 1984
- Mr. Cheng Hui BianDeputy General Manager · born 1972
- Ms. Xiao Jing WuDeputy General Manager · born 1986
- Mr. Zhaofeng LiuHead of Accounting Department & Accounting Supervisor